z-logo
Premium
The Need for Precompetitive Integrative Bionetwork Disease Model Building
Author(s) -
Friend S H
Publication year - 2010
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2010.40
Subject(s) - medicine
If you doubt that there are enormous gaps in the current drug discovery process, you should probably skip to the next article. Yet even while critiques rightly highlight inefficiencies or operational issues, they often miss a fundamental reality: until we better understand diseases as altered bionetworks and view diseases at an individual patient level, efforts to develop effective biomarkers and therapies will be inefficient at best. Clinical Pharmacology & Therapeutics (2010) 87 5, 536–539. doi: 10.1038/clpt.2010.40

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here